2022. Appropriate utilization of the prognostic 40-gene expression profile (40-GEP) test for cutaneous squamous cell carcinoma (cSCC) demonstrated by clinical reports and physician evaluation of real-world cases. SKIN The Journal of Cutaneous Medicine. 6, 2 (Mar. 2022), s21. DOI:https://doi.org/10.25251/skin.6.supp.21.